Reaktion #1095881

ord-cdef08b07cfa4de8a3e1ec6a84854467

Reaktionsgleichung

[Cl-].[NH4+]
ammonium chloride
[H-].[Na+]
sodium hydride
CC1(C)CCCNC1.Cl
3,3-dimethylpiperidine hydrochloride
CC#CCOc1ncnc(Cl)c1F
4-(2-butynyloxy)-6-chloro-5-fluoropyrimidine
CC#CCOc1ncnc(N2CCCC(C)(C)C2)c1F
4-(2-butynyloxy)-6-(3,3-dimethylpiperidino)-5-fluoropyrimidine
Ausbeute 18.1%

Lösungsmittel

Reaktionsbedingungen

Temperatur
60°CELSIUS
Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    TemperaturAfter the reaction mixture was cooled to near room temperature
  2. 2
    Extraktionthe mixture was extracted with tert-butyl methyl ether three times
  3. 3
    WaschenThe organic layers were washed with a saturated sodium chloride aqueous solution
  4. 4
    Trocknendried over anhydrous magnesium sulfate
  5. 5
    Einengenconcentrated

Vorschrift

0.12 g of sodium hydride (60% oil suspension) was suspended in 2 ml of tetrahydrofuran. 0.18 g of 3,3-dimethylpiperidine hydrochloride and 0.20 g of 4-(2-butynyloxy)-6-chloro-5-fluoropyrimidine were added therein, and the mixture was stirred for 1 hour at 60° C. After the reaction mixture was cooled to near room temperature, a saturated ammonium chloride aqueous solution was added therein, and the mixture was extracted with tert-butyl methyl ether three times. The organic layers were washed with a saturated sodium chloride aqueous solution, dried over anhydrous magnesium sulfate and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.05 g of 4-(2-butynyloxy)-6-(3,3-dimethylpiperidino)-5-fluoropyrimidine (hereinafter, referred to as Compound (32)).

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US07973028B2uspto-grants-2011_07